Novartis profit falls short as Chiron weighs
681000
Novartis  missed  expectations with a 4 percent rise in second-quarter net income  to &#36;1.713 billion on Monday, as heavy charges from the Swiss  drug giant&#039;s acquisition of U.S. biotech firm Chiron weighed.
505951
U.S. oil and gas producer XTO Energy Inc.  on Tuesday said its fourth-quarter profit fell as lower natural gas prices weighed on results.
105442
Eli Lilly and Co.  on Thursday forecast profit gains next year below its expected 2006 growth and offered few big surprises at a meeting to describe its experimental drugs, sending shares lower.
445624
Noble Energy Inc.  said on  Thursday its fourth-quarter profit fell as weakness in natural  gas prices weighed on results.
468942
Merck & Co. MRK.N on Thursday said  its quarterly profit fell 28 percent due to last month's recall  of its Vioxx arthritis drug, and the company predicted 2004  earnings will fall as much as 11 percent because of the recall.
715918
Steelmaker Nucor Corp.  said on Monday it expects second-quarter earnings to be well below Wall Street expectations, hurt by lower shipments from its bar mill group.
196100
Third-quarter profit fell 1 percent, as stronger sales of almost all of the companyâs key drugs could not offset  higher production costs and taxes and a restructuring charge.
650282
The chemical maker reported a quarterly profit that was lower than expected, in part due to weak demand from the housing and auto markets.
628857
Biotechnology company Genentech Inc  said on Monday its fourth-quarter profit rose 6.4 percent, but sales of its blockbuster cancer drug and others fell short of investor expectations, sending the company's shares lower.
655985
Pharmaceutical wholesaler McKesson  Corp  reported on Thursday that its quarterly profit  fell 17 percent as results were hurt by lower profit margins on  certain generic drugs and charges taken.
244313
BASEL, Switzerland  - Core net profit at Roche  Holding AG rose by less than expected in 2004 despite strong  sales of cancer drugs, as products such as flu drug Tamiflu  suffered a weaker fourth quarter.
582487
Lawnmower maker the Toro Company  said on Thursday quarterly earnings slipped in line with falling revenue, but beat estimates as growth in its professional segment helped offset lower domestic residential segment sales.
191741
Boston Scientific Corp.  posted a lower-than-expected quarterly profit on Friday as sales of its flagship drug-eluting heart stent fell by 32 percent.
716268
Bristol-Myers Squibb Co., a major drug maker, reported on Friday that its third-quarter profit fell 16 percent as the company continues to struggle with loss of patent protection
113641
Chiron Corp. CHIR.O on Tuesday  slashed its 2004 earnings forecast after announcing that it  will not record any sales of its flu vaccine for the 2004-2005  flu season, sending its shares down 18 percent.
739004
Medical device maker Medtronic Inc  on Tuesday said quarterly earnings fell on charges related to the acquisition of Kyphon.
261610
U.S. oil and gas producer XTO Energy  Inc.  on Tuesday said its fourth-quarter profit fell as  lower natural gas prices weighed on results.